Vol. 83, Issue 1, 2020January 17, 2020 EDT
BANNING OFF-LABEL DRUG PROMOTION OFFENDS THE U.S. CONSTITUTION: MAKING THE STRONGEST CASE
BANNING OFF-LABEL DRUG PROMOTION OFFENDS THE U.S. CONSTITUTION: MAKING THE STRONGEST CASE
U.S. Food and Drug Administration “off-label” uses approved therapeutic products First Amendment commercial free speech principles U.S. Supreme Court brand-name competitors
Lars Noah, BANNING OFF-LABEL DRUG PROMOTION OFFENDS THE U.S. CONSTITUTION: MAKING THE STRONGEST CASE, 83 Albany Law Review (2020).
Powered by Scholastica, the modern academic journal management system